MagicMed Closes Oversubscribed $1.6M Private Placement to Build Out Its Psybrary™
September 21, 2020
Psychedelics: Investing in the Perfect BrainStorm
April 3, 2020
5 Ways to Participate in the Psychedelics Boom
March 27, 2020
The Effort to Decriminalize Psilocybin in California is Underway
CaliforniaUncategorized February 24, 2020
Psilocybin has been in the news with increasing frequency as research into psychedelic therapy has proliferated, and a number of local jurisdictions, including the cities of Oakland, Denver, and Santa Cruz have decriminalized psilocybin to varying degrees. Much like cannabis, public perception of certain psychedelics like psilocybin is shifting rapidly, as people really the incredible…
Read more
The Psilocybin Movement is Like the Cannabis Movement (Except When It’s Not)
Uncategorized February 20, 2020
There is a bona fide movement underway with psilocybin. Decriminalization occurred last year in Denver, Oakland and Santa Cruz, and that was just a start: nearly 100 other cities are looking at decriminalizing psychedelics. At the state level, ballot measures are out for signature in California and Oregon. Federally, legislation has been proposed to allow…
Read more
USPTO Grants Trademark for PSILOCYBIN, But Don’t Get Too Worked Up Yet
Uncategorized February 5, 2020
A few weeks back, Twitter was abuzz about the fact that the United State Patent and Trademark Office (“USPTO”) granted a federal trademark registration for the word PSILOCYBIN. The mark was registered by the company Black Pandas LLC and applies to the following services in Class 041: “Development and dissemination of education materials of others…
Read more
This Psilocybin Patent Could Be a Really Big Deal
Uncategorized January 22, 2020
Last week, COMPASS Pathways announced its acquisition of US Patent No 10,591,175. What does that patent cover? Psilocybin! More specifically, COMPASS has locked down “methods of treating drug-resistant depression with a psilocybin formulation.” The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post…
Read more
